Is Procter & Gamble's Stock Cheap or Expensive by the Numbers?

Numbers can lie -- yet they're the best first step in determining whether a stock is a buy. In this series, we use some carefully chosen metrics to size up a stock's true value based on the following clues:

  • The current price multiples.
  • The consistency of past earnings and cash flow.
  • How much growth we can expect.

Let's see what those numbers can tell us about how expensive or cheap Procter & Gamble (NYS: PG) might be.

The current price multiples
First, we'll look at most investors' favorite metric: the P/E ratio. It divides the company's share price by its earnings per share (EPS) -- the lower, the better.

Then we'll take things up a notch with a more advanced metric: enterprise value to unlevered free cash flow, which divides the company's enterprise value (basically, its market cap plus its debt, minus its cash) by its unlevered free cash flow (its free cash flow, adding back the interest payments on its debt). As with the P/E, the lower this number is, the better.

Analysts argue about which is more important -- earnings or cash flow. Who cares? A good buy ideally has low multiples on both.

Procter & Gamble has a P/E ratio of 15.4 and an EV/FCF ratio of 21.6 over the trailing 12 months. If we stretch and compare current valuations with the five-year averages for earnings and free cash flow, we see that Procter & Gamble has a P/E ratio of 14.9 and a five-year EV/FCF ratio of 17.9.

A positive one-year ratio of less than 10 for both metrics is ideal (at least in my opinion). For a five-year metric, less than 20 is ideal.

Procter & Gamble has a mixed performance in hitting the ideal targets, but let's see how it stacks up against some of its competitors and industry mates. 


1-Year P/E

1-Year EV/FCF

5-Year P/E

5-Year EV/FCF

Procter & Gamble 15.4 21.6 14.9 17.9
Clorox 19.1 21.5 16.8 17.8
Kimberly-Clark 17.0 18.6 16.1 17.6
Johnson & Johnson 15.6 13.5 14.7 12.6

Source: S&P Capital IQ; NM = not meaningful because of losses.

Numerically, we've seen how Procter & Gamble's valuation rates on both an absolute and relative basis. Next, let's examine ...

The consistency of past earnings and cash flow
An ideal company will be consistently strong in its earnings and cash-flow generation.

In the past five years, Procter & Gamble's net income margin has ranged from 13.8% to 17.7%. In that same time frame, unlevered free cash flow margin has ranged from 11.7% to 18.2%.

How do those figures compare with those of the company's peers? See for yourself:


Source: S&P Capital IQ; margin ranges are combined.

Source: S&P Capital IQ; margin ranges are combined.

In addition, over the past five years, Procter & Gamble has tallied up five years of positive earnings and five years of positive free cash flow.

Next, let's figure out ...

How much growth we can expect
Analysts tend to comically overstate their five-year growth estimates. If you accept them at face value, you will overpay for stocks. But even though you should definitely take the analysts' prognostications with a grain of salt, they can still provide a useful starting point when compared with similar numbers from a company's closest rivals.

Let's start by seeing what this company's done over the past five years. In that time period, Procter & Gamble has put up past EPS growth rates of 7.9%. Meanwhile, Wall Street's analysts expect future growth rates of 9%.

Here's how Procter & Gamble compares with its peers for trailing-five-year growth:


Source: S&P Capital IQ; EPS growth shown.

Source: S&P Capital IQ; EPS growth shown.

And here's how it measures up with regard to the growth analysts expect over the next five years:


Source: S&P Capital IQ; estimates for EPS growth.

Source: S&P Capital IQ; estimates for EPS growth.

The bottom line
The pile of numbers we've plowed through has shown us the price multiples that shares of Procter & Gamble are trading at, the volatility of its operational performance, and what kind of growth profile it has -- both on an absolute and a relative basis.

The more consistent a company's performance has been and the more growth we can expect, the more we should be willing to pay. We've gone well beyond looking at a 15.4 P/E ratio, and we see that P&G's price multiples are pretty reasonable on a five-year basis given its strong, consistent margins and low but solid growth.  

P&G's performance is driven by its market-leading brands (like Tide detergent), and I'm a fan of the business. Right now, I find its stock neither excessively cheap nor excessively expensive. Meanwhile, our CAPS community rates it five stars out of five.

But all this is just a start. If you find Procter & Gamble's numbers or story compelling, don't stop here. Continue your due-diligence process until you're confident one way or the other. As a start, add it to My Watchlist to find all of our Foolish analysis.

If you'd like to read more about P&G and 10 other dividend-paying stocks, check out our free report: "Secure Your Future With 11 Rock-Solid Dividend Stocks."

At the time this article was published Anand Chokkavelu owns shares of Johnson & Johnson. The Motley Fool owns shares of Clorox and Johnson & Johnson. Motley Fool newsletter services have recommended buying shares of Johnson & Johnson, Kimberly-Clark, and Procter & Gamble and creating a diagonal call position in Johnson & Johnson. Try any of our Foolish newsletter services free for 30 days. We Fools don't all hold the same opinions, but we all believe that considering a diverse range of insights makes us better investors. The Motley Fool has a disclosure policy.

Copyright © 1995 - 2012 The Motley Fool, LLC. All rights reserved. The Motley Fool has a disclosure policy.

Increase your money and finance knowledge from home

Investor’s Toolbox

Improve your investing savvy with the right financial toolset.

View Course »

Goal Setting

Want to succeed? Then you need goals!

View Course »

Add a Comment

*0 / 3000 Character Maximum

1 Comment

Filter by:


January 23 2012 at 2:35 PM Report abuse rate up rate down Reply